Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 1
2017 2
2019 1
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
Trullàs JC, Morales-Rull JL, Casado J, Carrera-Izquierdo M, Sánchez-Marteles M, Conde-Martel A, Dávila-Ramos MF, Llácer P, Salamanca-Bautista P, Pérez-Silvestre J, Plasín MÁ, Cerqueiro JM, Gil P, Formiga F, Manzano L; CLOROTIC trial investigators. Trullàs JC, et al. Eur Heart J. 2023 Feb 1;44(5):411-421. doi: 10.1093/eurheartj/ehac689. Eur Heart J. 2023. PMID: 36423214 Clinical Trial.
Beta-blocker use in patients with heart failure with preserved ejection fraction and sinus rhythm.
Formiga F, Chivite D, Nuñez J, Moreno García MC, Manzano L, Arévalo-Lorido JC, Cerqueiro JM, García Campos Á, Trullàs JC, Montero-Pérez-Barquero M; RICA Investigators group. Formiga F, et al. Rev Port Cardiol. 2022 Oct;41(10):853-861. doi: 10.1016/j.repc.2021.06.027. Epub 2022 Jul 29. Rev Port Cardiol. 2022. PMID: 36207068 Free article. English, Portuguese.
Projected clinical benefits of dapagliflozin in patients with heart failure with preserved ejection fraction.
Montero-Pérez-Barquero M, Escobar-Cervantes C, Llàcer P, Quirós-López R, Trullás JC, Cerqueiro JM, Epelde-Gonzálo F, Carrera-Izquierdo M, Formiga F, González-Franco A, Casado-Cerrada J. Montero-Pérez-Barquero M, et al. Among authors: cerqueiro jm. Future Cardiol. 2023 May;19(6):333-342. doi: 10.2217/fca-2023-0015. Epub 2023 Jun 29. Future Cardiol. 2023. PMID: 37382199
Heart Failure Programs / Units. A Multidisciplinary Approach.
Manzano L, González-Franco Á, Cerqueiro JM, Montero Pérez-Barquero M. Manzano L, et al. Rev Esp Cardiol (Engl Ed). 2017 May;70(5):410. doi: 10.1016/j.rec.2017.03.005. Epub 2017 Mar 28. Rev Esp Cardiol (Engl Ed). 2017. PMID: 28363710 English, Spanish. No abstract available.
Prognostic Impact of the UMIPIC Program in the Follow Up in Patients with Heart Failure and Cardiorenal Syndrome.
Méndez-Bailón M, Lorenzo-Villalba N, González-Franco Á, Manzano L, Casado-Cerrada J, Cerqueiro JM, Pérez-Silvestre J, Arévalo-Lorido JC, Conde-Martel A, Dávila-Ramos MF, Carrera-Izquierdo M, Andrès E, Montero-Pérez-Barquero M. Méndez-Bailón M, et al. Among authors: cerqueiro jm. J Clin Med. 2023 Nov 23;12(23):7261. doi: 10.3390/jcm12237261. J Clin Med. 2023. PMID: 38068309 Free PMC article.
Has beta-blocker use increased in patients with heart failure in internal medicine settings? Prognostic implications: RICA registry.
González-García A, Montero Pérez-Barquero M, Formiga F, González-Juanatey JR, Quesada MA, Epelde F, Oropesa R, Díez-Manglano J, Cerqueiro JM, Manzano L; RICA registry investigators. González-García A, et al. Among authors: cerqueiro jm. Rev Esp Cardiol (Engl Ed). 2014 Mar;67(3):196-202. doi: 10.1016/j.rec.2013.07.012. Epub 2013 Nov 9. Rev Esp Cardiol (Engl Ed). 2014. PMID: 24774394
Effect of a Therapeutic Strategy Guided by Lung Ultrasound on 6-Month Outcomes in Patients with Heart Failure: Randomized, Multicenter Trial (EPICC Study).
Bailón MM, Rodrigo JMC, Lorenzo-Villalba N, Cerqueiro JM, García JC, Manuel EC, Martín-Sánchez FJ, Freire RB, Romano PC, Espinosa LM, Arévalo-Lorido JC, Rojo JMC, Macho JT; Spanish Study Groups of Heart Failure and Clinical Echography of the Spanish National Society of Internal Medicine. Bailón MM, et al. Cardiovasc Drugs Ther. 2019 Aug;33(4):453-459. doi: 10.1007/s10557-019-06891-z. Cardiovasc Drugs Ther. 2019. PMID: 31332655